Galera appoints mark j. bachleda as chief commercial officer and jennifer evans stacey as chief legal and compliance officer

Malvern, pa., oct. 12, 2021 (globe newswire) -- galera therapeutics, inc. (nasdaq: grtx), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer, today announced the appointment of mark j. bachleda, pharm.d., m.b.a., as chief commercial officer (cco) and jennifer evans stacey, esq., as chief legal and compliance officer (clco) and secretary. both executives join galera with over 25 years of leadership experience within the biopharmaceutical industry.
GRTX Ratings Summary
GRTX Quant Ranking